Psychedelic medicine,
here and now

A growing network of psychiatry clinics, research sites and therapeutic retreats specialized in psychedelic medicine

What we do

Empowering healing

Clinical care

Ketamine-assisted psychotherapy + other innovative therapies

Clinical research

Psychedelic clinical trials and protocol development

Therapeutic retreats

Legal, medically supervised psychedelic experiences

Our network

A global network dedicated to psychedelic medicine

  • Providing access to innovative, evidence based mental healthcare

  • Patients are referred to trusted partners for treatments not yet available in the US

  • Only active in jurisdictions with established regulations for the use of psychedelics

  • Our approach

    Helping people, right now

    Novamind enables safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites.

    We provide ketamine-assisted psychotherapy and other novel treatments through our network of Cedar Psychiatry clinics and operate Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.

    Through our retreat partners, we offer additional access to psychedelics in jurisdictions with established regulations for the use of these alternative medicines.

    Our healthcare divisions

    Our retreat partners

    Our retreat partners

    Why psychedelics?

    “Psychedelics, used responsibly and with proper caution, would be for psychiatry what the microscope is for biology or the telescope is for astronomy.”

    — Stanislav Grof, MD